Graham Thompson joined FDA in 2012 and currently serves as an operations research analyst for the Decision Support and Analysis Staff (DSAS) in FDA’s Center for Drug Evaluation and Research (CDER). He works on CDER projects and initiatives related to benefit-risk assessment and supporting programmatic and regulatory decisions. With DSAT, he is a co-lead for guidance development as well as advancing benefit-risk assessment and decision analysis methodologies. Graham has previously worked on CDER’s various Patient-Focused Drug Development initiatives and efforts to facilitate the incorporation of patient input into decision-making. Graham also has experience working on PDUFA negotiations and other strategic, regulatory, and policy efforts.